USA – The FDA has approved two once-daily, oral JAK inhibitors on for patients with moderate-to-severe atopic dermatitis whose disease is not well controlled with other systemic medications, including biologics,…
Read MoreTag: Cibinqo
New warnings added to the labels of arthritis medications amid JAK medications safety reviews
USA – The Food and Drug Administration (FDA) has added strictest warnings to the labels of JAK inhibitors, a class of drugs used to treat arthritis manufactured by Pfizer, Eli…
Read More